Akebia: Chief Commercial Officer Nicholas Grund tritt per 6. November 2026 zurück

• Nicholas Grund tritt als Senior Vice President und Chief Commercial Officer zurück; wirksam per 6. November 2026.
• Rücktritt aus persönlichen Gründen angekündigt; Mitteilung an das Unternehmen am 7. Oktober 2026.
• Beratungsmandat ab Rücktrittsdatum bis 30. April 2027; vorzeitige Beendigung mit Fristen möglich.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Akebia Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001517022-26-000071), on October 14, 2026, and is solely responsible for the information contained therein.